menu search

Dna repair drugs market to grow at 6.5% cagr, touching us$ 10.4 bn by 2031: tmr study

Increase in usage of DNA repair drugs as a combination therapy for improving treatment outcomes in ovarian and breast cancer is antici...

July 5, 2023, 11:15 am

Meta won't launch twitter-like threads app in european union due to regulatory concerns

Meta has apparently skipped launching its highly anticipated Twitter-like app “Threads” in European...

July 5, 2023, 10:58 am

Grifols: a promising buy opportunity

Grifols is a promising buy opportunity thanks to its potential to reduce its net debt/EBITDA ratio. The company's focus on deleveraging is showing res...

July 5, 2023, 10:56 am

3 cash-rich defensive companies making investors rich

To a local restaurant that only accepts cash payments, ‘cash is king.' To investors in an overheated stock market, a ‘cash is king' strategy keeps...

July 5, 2023, 10:18 am

Netflix (nflx) expands portfolio with the burning body launch

Netflix (NFLX) recently announced that its highly anticipated miniseries, The Burning Body, is set to p...

July 5, 2023, 10:02 am

Genprex granted chinese patent for lead drug candidate reqorsa with pd-1 antibodies to treat cancers

Genprex Inc. revealed that the China National Intellectual Property Administration has granted it a broad pat<...

July 5, 2023, 9:47 am

Oil industry should set carbon targets at cop28 -totalenergies ceo

The world's oil and gas companies should set targets to cut greenhouse gas emissions by 2030 at the upcoming COP28 global climate conference, the CEO ...

July 5, 2023, 9:08 am

Awaiting federal reserve minutes: euro/dollar - overview for july 05, 2023

The EUR/USD pair is showing a decline as market participants eagerly anticipate the release of the Fede...

July 5, 2023, 8:44 am

Sarepta therapeutics completes sale of priority review voucher for $102 million

Sarepta Therapeutics Inc. SRPT, -0.90% said Wednesday it has completed the sale of its Rare Pediatric Disease Priority Review Voucher for $102 million...

July 5, 2023, 8:37 am

Markforged holding corporation: more patience is required

Markforged Holding Corporation, a 3D printing company, has not performed all that well as of late, despite having a significant amount of cash and cas...

July 5, 2023, 8:34 am

4 stocks backed by high efficiency to boost portfolio returns

Invest in companies like GMS (GMS), ABB (ABBNY), Eagle Materials (EXP) and patterson Companies (PDCO) t...

July 5, 2023, 8:32 am

Understanding the hanging man candlestick pattern

The hanging man candlestick pattern suggests a potential market reversal. This article will explain how...

July 5, 2023, 8:25 am

Arway.ai unveils highly anticipated version 2.5 update

ARway.ai (CSE:ARWY, OTCQB:ARWYF) has unveiled its highly anticipated version 2.5 update, featuring a h...

July 5, 2023, 8:12 am

Usdchf technical analysis

The US data continued to surprise to the upside since the last FOMC meeting and that lead the market to price in a more hawkish ...

July 5, 2023, 8:09 am

Aud/usd price forecast: pmi’s hurt aussie dollar ahead of fomc minutes

AUD/USD bears begin the day in charge but with FOMC minutes to come, will we see a breakout from the developing ascending triangle ...

July 5, 2023, 7:55 am

Ionis to present at upcoming investor conference

CARLSBAD, Calif. , July 5, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will partici...

July 5, 2023, 7:05 am

This value investor lunched with warren buffett and cornered bill gates. here's his take on ai, nvidia and microsoft.

Who right now could be considered to be the Joey Chestnut of investing? Click here to participate in th...

July 5, 2023, 6:42 am

Halozyme: inflection point with argenx's vyvgart sc approval (reiterating buy)

argenx's Vyvgart Hytrulo, a game-changer with its 1-minute SC formulation, opens a new revenue stream for Halozyme with sales expected to surpass $10B...

July 5, 2023, 6:24 am

3 top stocks to buy now and hold forever

Intuitive Surgical's robotic systems are improving patient outcomes. ExxonMobil is quickly becoming a l...

July 5, 2023, 4:52 am

Eur/chf daily outlook

Daily Pivots: (S1) 0.9746; (P) 0.9767; (R1) 0.9780; More… EUR/CHF is extending the sideway pattern fr...

July 5, 2023, 2:59 am


Search within

Pages Search Results: